Blue Bell Private Wealth Management’s Twist Bioscience TWST Stock Holding History

Blue Bell Private Wealth Management’s Portfolio TWST Stock Details TWST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-166	Closed	-$7.89K	–	755
2026 Q1	$7.89K	Hold	166	–	–	﹤0.01%	586
2025 Q4	$5.27K	Hold	166	–	–	﹤0.01%	600
2025 Q3	$4.67K	Hold	166	–	–	﹤0.01%	600
2025 Q2	$6.11K	Sell	166 -100	-38%	-$3.46K	﹤0.01%	565
2025 Q1	$10.4K	Hold	266	–	–	﹤0.01%	514
2024 Q4	$12.4K	Hold	266	–	–	﹤0.01%	479
2024 Q3	$12K	Hold	266	–	–	﹤0.01%	506
2024 Q2	$13.1K	Buy	266 +100	+60%	+$4.08K	﹤0.01%	491
2024 Q1	$5.7K	Hold	166	–	–	﹤0.01%	562
2023 Q4	$6.12K	Hold	166	–	–	﹤0.01%	543
2023 Q3	$3.36K	Hold	166	–	–	﹤0.01%	536
2023 Q2	$3.4K	Hold	166	–	–	﹤0.01%	542
2023 Q1	$2.5K	Hold	166	–	–	﹤0.01%	535
2022 Q4	$3.95K	Hold	166	–	–	﹤0.01%	491
2022 Q3	$6K	Hold	166	–	–	﹤0.01%	450
2022 Q2	$6K	Hold	166	–	–	﹤0.01%	484
2022 Q1	$8K	Hold	166	–	–	﹤0.01%	473
2021 Q4	$13K	Buy	+166	New	+$17K	﹤0.01%	366

Other funds holding TWST

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Blue Bell Private Wealth Management's TWST Position: Q2 2026 in Review

Blue Bell Private Wealth Management sold out of Twist Bioscience (TWST) in Q2 2026, closing a stake of 166 shares — an estimated $7.89K sold.

Blue Bell Private Wealth Management first reported a position in TWST in Q4 2021 and held it in 18 quarters. The position peaked at $13.1K in Q2 2024. 337 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

Blue Bell Private Wealth Management reported no remaining Twist Bioscience position as of Q2 2026 after selling out during the quarter.
Blue Bell Private Wealth Management sold 166 Twist Bioscience shares in Q2 2026, an estimated $7.89K.
Blue Bell Private Wealth Management first reported a position in Twist Bioscience in Q4 2021 and held it in 18 quarters.
Blue Bell Private Wealth Management's Twist Bioscience position peaked at $13.1K in Q2 2024.
337 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on Blue Bell Private Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.